glp 1 frequency Patients who reduced the of GLP-1 dosing (from weekly to every other week) were able to maintain their weight loss and metabolic syndrome gains, as reported in this case series. Findings New oral GLP-1 drug delivers

Researchers often study the balance between GSH and GSSG to assess cellular antioxidant status

A monomolecular coagonist (tirzepatide) of receptors for both incretin hormones (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide) produced HbA1c values below 5.7% in 50% of the treated patients and weight losses exceeding 20% in obese individuals

Castelli S, De Falco P, Ciccarone F, Desideri E, Ciriolo MR

Superior Appetite Control: Significantly delays gastric emptying and suppresses hunger signals more effectively than first-generation peptides

Yin Y-H, Liu JYW, Vlimki M

YQ: Writing review & editing